In this phase I , double-blinded , placebo-controlled trial , 37 healthy volunteers were randomized to three treatment arms : 0.5 % cis-UCA ( 12 subjects ) , 2.5 % cis-UCA ( 12 subjects ) and placebo eye drops ( 13 subjects ) .